No Data
Is Chongqing Lummy Pharmaceutical (SZSE:300006) Using Too Much Debt?
Chongqing Lummy Pharmaceutical (300006.SZ) Shareholder Qiu Yu has completed the Shareholding period, having reduced holdings by a total of 6.8792 million shares.
Chongqing Lummy Pharmaceutical (300006.SZ) announced that the Shareholder Qiu Yu's Shareholding plan has expired, with a total decrease in the company's share...
Laimei Pharmaceuticals: 2024 performance forecast
Risks Still Elevated At These Prices As Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE:300006) Shares Dive 36%
Guangxi Wuzhou Zhongheng Group (600252.SH): The public solicitation of some shares of Chongqing Lummy Pharmaceutical is temporarily suspended.
On December 27, Gala Exchange reported that Guangxi Wuzhou Zhongheng Group (600252.SH) announced that on December 13, 2024, it disclosed the "Announcement on the Public Collection of Buyers for the Proposed Agreement Transfer of Shares of Chongqing Lummy Pharmaceutical Co., Ltd." on the Shanghai Stock Exchange website. The company plans to transfer 247,426,064 unrestricted circulating A-share stocks of Chongqing Lummy Pharmaceutical Co., Ltd. (referred to as "Lummy Pharmaceutical"), which accounts for 23.43% of Lummy Pharmaceutical's total share capital, through a public collection of buyers.
Further Weakness as Chongqing Lummy Pharmaceutical (SZSE:300006) Drops 13% This Week, Taking Three-year Losses to 33%
Chongqing Lummy Pharmaceutical Co., Ltd.'s (SZSE:300006) Popularity With Investors Under Threat As Stock Sinks 28%
